Cancer News and Research

Latest Cancer News and Research

Proton therapy reduces treatment side effects among head and neck cancer patients

The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.

25 Sep 2013

Researchers blame HPV for increased number of young adults with oropharyngeal cancer

The human papillomavirus (HPV) may be to blame for the alarming increase of young adults with oropharyngeal cancer, according to researchers from Henry Ford Hospital in Detroit.

25 Sep 2013

miR-31 in primary tumor cells predicts lymph node metastasis in NSCLC patients

Determining whether a patient's lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question.

25 Sep 2013

Amendment to renal cancer TNM staging proposed

Patients with pT3a renal cell carcinoma have markedly worse survival rates if they have both fat invasion and renal vein thrombosis, rather than just one of these factors, a study shows.

24 Sep 2013

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

24 Sep 2013

Metastatic site impacts survival in targeted RCC treatment

Bone and liver metastases may have the heaviest impact on the survival of patients receiving targeted therapy for metastatic renal cell carcinoma, suggest data from the International Metastatic Renal Cell Carcinoma Database Consortium.

24 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013

Pancreatic Cancer Imaging Agent Earns Mabvax $1.75M SBIR Award

...

24 Sep 2013

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).

24 Sep 2013

New And Improved Method For Analyzing Single-Cell Gene Expression

...

24 Sep 2013

Dental caries show ‘unexpected’ relationship with head and neck cancer

People with dental caries have a reduced risk for developing head and neck squamous cell carcinoma, a large case-control study has found.

24 Sep 2013

Sulfasalazine drug does not reduce diarrhea for patients receiving pelvic radiation therapy: Study

Sulfasalazine, a drug commonly prescribed to reduce diarrhea in patients with inflammatory bowel disease, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area a Mayo Clinic-led study has found.

24 Sep 2013

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

In a paper just published electronically in the Journal of Alzheimer's Disease, dramatic increases in Alzheimer's disease in Japan and significant increases in developing countries are linked to changes in national diets.

24 Sep 2013

Stereotactic radiosurgery improves survival in adult brain cancer patients under 50

When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

The American Society for Radiation Oncology will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO's 55th Annual Meeting, September 22-25, 2013, in Atlanta.

24 Sep 2013

Messages that warn consumers about potentially harmful side effects increase product sales

Drug ads often warn of serious side effects, from nausea and bleeding to blindness, even death. New research suggests that, rather than scaring consumers away, these warnings can improve consumers' opinions and increase product sales when there is a delay between seeing the ad and deciding to buy or consume the product.

24 Sep 2013

UNM Cancer Center Radiation Oncology Department gets ACR accreditation

The University of New Mexico Cancer Center Radiation Oncology Department recently received the widely recognized accreditation from the American College of Radiology.

24 Sep 2013

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

A secondary analysis of the historic RTOG 9202 prostate cancer trial examined results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy, and concluded that there were no additional benefits when compared to short-term hormonal therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Adults across the U.S. rate childhood cancer as top priority for research into improving children's health

Adults across the U.S. rate childhood cancer as their top priority for research into improving children's health, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

24 Sep 2013

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Cancer News and Research

Latest Cancer News and Research

Proton therapy reduces treatment side effects among head and neck cancer patients

Researchers blame HPV for increased number of young adults with oropharyngeal cancer

miR-31 in primary tumor cells predicts lymph node metastasis in NSCLC patients

Amendment to renal cancer TNM staging proposed

Inflammatory marker may highlight aggressive RCC treatment need

Metastatic site impacts survival in targeted RCC treatment

Quartette tablets now available in U.S. for prevention of pregnancy

Pancreatic Cancer Imaging Agent Earns Mabvax $1.75M SBIR Award

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

New And Improved Method For Analyzing Single-Cell Gene Expression

Dental caries show ‘unexpected’ relationship with head and neck cancer

Sulfasalazine drug does not reduce diarrhea for patients receiving pelvic radiation therapy: Study

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

Stereotactic radiosurgery improves survival in adult brain cancer patients under 50

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

Messages that warn consumers about potentially harmful side effects increase product sales

UNM Cancer Center Radiation Oncology Department gets ACR accreditation

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

Adults across the U.S. rate childhood cancer as top priority for research into improving children's health

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in